US Patent Issued to Hoffmann-La Roche on Aug. 25 for "Antibodies binding to GPRC5D" (German, Swiss, French Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,923, issued on Aug. 25, was assigned to Hoffmann-La Roche Inc. (Branchburg, N.J.).

"Antibodies binding to GPRC5D" was invented by Alexander Bujotzek (Munich), Tony Christopeit (Schliersee, Germany), Tanja Fauti (Zurich), Georg Fertig (Penzberg, Germany), Helene Cecile Haegel (Illkirch-Graffenstaden, France), Christian Klein (Bonstetten, Switzerland), Thomas Kraft (Munich), Stefan Lorenz (Penzberg, Germany), Maud Lea Mayoux (Zurich, Switzerland) and Anneliese Schneider (Feldafing, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally relates to antibodies that bind to GPRC5D, including bispecific antigen binding molec...